# China NMPA Drug Inspection - Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. - Dexamethasone sodium phosphate injection

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/sinopharm-group-rongsheng-pharmaceutical-co-ltd/baa0d9a3-d29e-4e79-ac30-27eedd63b098/
Source feed: China

> China NMPA drug inspection for Sinopharm Group Rongsheng Pharmaceutical Co., Ltd. published October 29, 2021. Drug: Dexamethasone sodium phosphate injection. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: The Yunnan Provincial Drug Administration issued the third issue of its 2021 Drug Quality Bulletin.
- Company Name: Sinopharm Group Rongsheng Pharmaceutical Co., Ltd.
- Publication Date: 2021-10-29
- Drug Name: Dexamethasone sodium phosphate injection
- Inspection Finding: Compliant

Company: https://www.globalkeysolutions.net/companies/sinopharm-group-rongsheng-pharmaceutical-co-ltd/a6ab5514-40e8-4501-ae61-1775a7410d0f/